NCT02075619View on ClinicalTrials.gov

Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 24, 2014

Primary Completion Date

July 11, 2014

Study Completion Date

July 11, 2014

Conditions
Hypertension
Interventions
DRUG

Amlodipine+Rosuvastatin

Amlodipine 10mg will be supplied as white or off-white, emerald shaped tablet. Rosuvastatin 20mg will be supplied as pink round film coated tablet.

DRUG

GSK3074477 FDC - 1

GSK3074477 containing combination of 10mg amlodipine and 20mg rosuvastatin, will be supplied as white caplet shaped film coated tablet.

DRUG

GSK3074477 FDC - 2

GSK3074477 containing combination of 10mg amlodipine and 20mg rosuvastatin, will be supplied as white caplet shaped film coated tablet.

Trial Locations (1)

169608

GSK Investigational Site, Singapore

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
collaborator

SingHealth Investigational Medicine Unit, Singapore

UNKNOWN

lead

GlaxoSmithKline

INDUSTRY

NCT02075619 - Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions | Biotech Hunter | Biotech Hunter